MJ18, a monoclonal antibody against B7-H3, has been shown to significantly reduce tumour volume in the Tgfbr1/Pten 2Cko mouse model without causing additional cytotoxicity and to effectively reverse the immunosuppressive state [75]. This evidence concerns the gene CD276 and neoplasm.